Who backs Be Biopharma?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| ARCH Venture Partners | Venture capital |
| Bristol-Myers Squibb | — |
| Atlas Venture | Other |
| Takeda Ventures | Venture capital |
| Alta Partners | — |
| Bristol-Myers Squibb Foundation | — |
| DC Investment Partners | — |
| Longwood Fund | — |
| Nextech Invest | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Be Biopharma
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Be Biopharma in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.